|
Volumn 124, Issue 3, 2006, Pages 225-228
|
Regulating stem cell research & therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE HEART INFARCTION;
ALZHEIMER DISEASE;
BIOSAFETY;
CELL NUCLEUS TRANSPLANTATION;
EDITORIAL;
EMBRYONIC STEM CELL;
FERTILIZATION IN VITRO;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE FACILITY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
LEGAL ASPECT;
MATERNAL WELFARE;
MEDICAL EXPERT;
MEDICAL RESEARCH;
MOLECULAR CLONING;
NEWBORN CARE;
NIDATION;
NONHUMAN;
PARENTAL CONSENT;
PARKINSON DISEASE;
PRACTICE GUIDELINE;
QUALITY CONTROL;
RESEARCH ETHICS;
RISK BENEFIT ANALYSIS;
SOCIAL ASPECT;
SOMATIC CELL;
SPINAL CORD INJURY;
STEM CELL TRANSPLANTATION;
STROKE;
TREATMENT INDICATION;
UMBILICAL CORD;
BIOMEDICAL RESEARCH;
EMBRYONIC STEM CELLS;
GOVERNMENT REGULATION;
INDIA;
RESEARCH EMBRYO CREATION;
STEM CELL TRANSPLANTATION;
|
EID: 33750964492
PISSN: 09715916
EISSN: 09715916
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (2)
|
References (6)
|